Indefinite Delivery Contract N6264522D5008
Award Date
9/22/22
Last Date to Order
9/30/27
Funding Federal Agency
Bureau of Medicine and Surgery
Contracting Federal Agency
Naval Supply Systems Command
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract (IDC) was awarded by the Naval Supply Systems Command (NAVSUP) to Center For Disease Detection, LLC, a subsidiary of Laboratory Corporation of America Holdings, to provide HIV-1+2 testing services. The single-award IDC has a ceiling value of $2,971,540 and a performance period ending on March 31, 2010. Several firm fixed-price delivery orders have been issued under the contract, totaling over $2.7 million, for HIV antibody and antigen screening services to be...
The federal contract IDV is awarded to Center For Disease Detection, LLC, a subsidiary of Laboratory Corporation of America Holdings, by the U.S. Department of Defense's Readiness Center. The contract has a ceiling value of $65,000,000 and a period of performance ending on September 30, 2029. The contract is for the provision of medical laboratory testing services to detect the antigens and antibodies of Human Immunodeficiency Virus (HIV), Hepatitis B Surface Antibody (HBsAb), Hepatitis B...
The Department of the Navy Bureau of Medicine and Surgery awarded a single-award indefinite delivery contract to BML, Inc. to provide laboratory testing services globally in support of Navy and Marine Corps medical programs. The base IDV has a potential value of $1,291,479.51 and period of performance from October 1, 2020 through September 30, 2023. Under the IDV, BML, Inc. has received numerous firm fixed price delivery orders for laboratory testing to be conducted in Japan, with no set-aside...
The Department of the Army Medical Command has awarded a series of firm fixed price delivery orders under a single award Indefinite Delivery Contract (IDC) to Center For Disease Detection, LLC (CDD), a subsidiary of Laboratory Corporation of America Holdings. The total value of the IDC is $64,292,584.96 with a period of performance through August 27, 2024. Under this IDC, CDD is providing HIV - AG/AB COMBO SCREENING TEST services to support the Army's medical programs and initiatives. Delivery...
This federal contract Indefinite Delivery Contract (IDC) was awarded by the U.S. Navy Bureau of Medicine and Surgery (BUMED), a defense agency, to Biomerieux Inc. through its Biomerieux, Inc. division. The contract has a ceiling value of $95,235 and a period of performance ending on September 30, 2020. Under this IDC, Biomerieux is providing its proprietary "Cost per Reportable Result (CPRR) Automated Blood Culture Analyzer" systems, reagents, and associated maintenance services to...
The federal contract IDV award is a multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract awarded by the Centers for Disease Control and Prevention (CDC) to Laboratory Corporation of America (LabCorp), a leading global life sciences company. The contract, titled "Test Surge and Data Sharing," has a ceiling value of $118,000,000 and a period of performance through September 5, 2029. LabCorp, doing business as Labcorp, is the prime contractor and provides comprehensive...
The federal contract IDV award is a Blanket Purchase Agreement (BPA) master contract between the Defense Health Agency (DHA) and Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract has a ceiling value of $8,000,000 and an ultimate completion date of January 24, 2030. Under this single-award BPA, Cepheid provides the DHA with reagents, testing kits, and consumable supplies for molecular diagnostic testing. Key products include GeneXpert diagnostic systems,...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (NIH-NIAID) has awarded a $36 million Indefinite Delivery/Indefinite Quantity (IDIQ) contract for the Diagnostic Pre-Clinical Services Program to Dynport Vaccine Company LLC, a subsidiary of General Dynamics Corp. Under this single-award IDIQ contract, Dynport will provide a wide range of services to support the development of in vitro diagnostic products for the...
This federal contract IDV, awarded by the U.S. Navy to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), provides a wide range of preclinical research services and support to help develop treatments and cures for respiratory diseases, infectious diseases, and other medical conditions. The $497 million multiple-award Navy Medicine R&D Support Omnibus III IDIQ contract vehicle has facilitated numerous delivery orders for LBERI, a subsidiary of the Lovelace Biomedical...
The federal contract IDV is an Indefinite Delivery Contract (IDC) awarded by the U.S. Navy Bureau of Medicine and Surgery (BUMED) to Leidos, Inc. for $82,065,981.62 over a period ending on September 17, 2025. The contract provides for a wide range of research support services for BUMED, including studies on traumatic brain injury, psychological health, cancer, and rare diseases. Several delivery order contracts have been issued under this IDC, valued at over $66 million in total. These task...